Digital companion apps help secure long-term habits during GLP-1 therapy
Glucagon-like peptide-1 (GLP-1) medications have revolutionized weight management, yet high dropout rates and rapid weight regain remain significant…
GLP-1 drugs appear psychiatrically safe, but one finding still raises questions
With millions of patients now taking GLP-1 drugs, researchers examined whether concerns about depression and suicidality are supported…
Semaglutide extended lifespan in older female mice, but that was not the only finding
A late-life experiment reveals how a widely used metabolic drug reshapes age-related physiology and molecular pathways, with effects…
New review highlights FOXA2’s role in glucose regulation pathways
A newly published review highlights the pivotal role of FOXA2, a key transcription factor, in coordinating pancreatic development,…
Ten-million-person study links semaglutide to lower COVID-19 mortality
After accounting for major health differences between semaglutide users and non-users, researchers identified a striking mortality association that…
Semaglutide and tirzepatide linked to fewer alcohol-related hospital visits
A large US health-record study suggests newer GLP-1 drugs may reduce alcohol-related acute-care visits, but the findings remain…
GLP-1 receptor activation linked to lower depression and bipolar disorder odds
Lifelong genetic differences associated with GLP-1 receptor activity point to possible mental health benefits beyond weight and glucose…
Semaglutide dose may matter more than weight loss for heart health
A large real-world study suggests semaglutide’s cardiovascular benefits may be more closely linked to the dose patients receive…
Nearly one in 10 Britons use or want weight-loss medication
A nationally representative survey estimates that millions of adults in Great Britain have already used GLP-1-based weight-loss medicines…
Gut microbiota may shape eating behavior and guide new obesity treatments
From appetite signals to food reward, researchers reveal how gut microbes may influence disordered eating and obesity, while…
GLP-1 medicines may cut clot-related risks in chronically inflamed patients
A large real-world analysis suggests GLP-1 receptor agonists may offer clot-related and survival benefits in a chronically inflamed,…
Could GLP-1 drugs help prevent breast cancer? New study points to a possible link
A major breast imaging study links GLP-1 agonists to lower breast cancer incidence, raising hopes for a new…